Bank of New York Mellon’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36B Sell
18,340,173
-373,190
-2% -$43.7M 0.39% 44
2026
Q1
$2.25B Sell
18,713,363
-451,163
-2% -$52.1M 0.41% 36
2025
Q4
$2.02B Sell
19,164,526
-2,629,828
-12% -$247M 0.36% 47
2025
Q3
$1.83B Sell
21,794,354
-203,076
-0.9% -$16.7M 0.33% 49
2025
Q2
$1.74B Sell
21,997,430
-1,133,427
-5% -$90.1M 0.33% 50
2025
Q1
$2.08B Sell
23,130,857
-1,082,680
-4% -$101M 0.41% 40
2024
Q4
$2.41B Buy
24,213,537
+5,550,824
+30% +$572M 0.44% 32
2024
Q3
$2.12B Sell
18,662,713
-489,577
-3% -$58.2M 0.39% 42
2024
Q2
$2.37B Sell
19,152,290
-490,649
-2% -$63.2M 0.45% 32
2024
Q1
$2.59B Sell
19,642,939
-1,186,987
-6% -$146M 0.5% 28
2023
Q4
$2.27B Sell
20,829,926
-4,162,431
-17% -$432M 0.46% 31
2023
Q3
$2.57B Sell
24,992,357
-1,724,945
-6% -$186M 0.57% 27
2023
Q2
$3.08B Sell
26,717,302
-2,431,676
-8% -$276M 0.65% 22
2023
Q1
$3.1B Sell
29,148,978
-1,246,651
-4% -$135M 0.68% 19
2022
Q4
$3.37B Sell
30,395,629
-653,582
-2% -$66.8M 0.77% 14
2022
Q3
$2.67B Sell
31,049,211
-1,531,264
-5% -$137M 0.65% 21
2022
Q2
$2.97B Sell
32,580,475
-212,053
-0.6% -$18.8M 0.68% 19
2022
Q1
$2.69B Buy
32,792,528
+1,822,084
+6% +$144M 0.52% 28
2021
Q4
$2.37B Buy
30,970,444
+1,636,358
+6% +$130M 0.43% 44
2021
Q3
$2.2B Sell
29,334,086
-286,219
-1% -$21.8M 0.43% 43
2021
Q2
$2.3B Sell
29,620,305
-2,417,608
-8% -$180M 0.45% 40
2021
Q1
$2.36B Sell
32,037,913
-1,300,197
-4% -$95.9M 0.48% 34
2020
Q4
$2.6B Sell
33,338,110
-1,064,002
-3% -$81.4M 0.57% 26
2020
Q3
$2.72B Buy
34,402,112
+1,323,166
+4% +$104M 0.67% 21
2020
Q2
$2.44B Sell
33,078,946
-3,412,457
-9% -$257M 0.65% 22
2020
Q1
$2.68B Buy
36,491,403
+43,281
+0.1% +$3.4M 0.89% 14
2019
Q4
$3.16B Sell
36,448,122
-1,100,653
-3% -$90.4M 0.82% 14
2019
Q3
$3.02B Buy
37,548,775
+114,428
+0.3% +$9.17M 0.83% 15
2019
Q2
$3B Sell
37,434,347
-902,701
-2% -$69.1M 0.82% 15
2019
Q1
$3.04B Sell
38,337,048
-1,569,877
-4% -$117M 0.85% 12
2018
Q4
$2.91B Sell
39,906,925
-949,396
-2% -$67M 0.91% 12
2018
Q3
$2.77B Buy
40,856,321
+325,766
+0.8% +$20.8M 0.71% 18
2018
Q2
$2.35B Buy
40,530,555
+3,420,228
+9% +$193M 0.64% 23
2018
Q1
$1.93B Buy
37,110,327
+123,409
+0.3% +$6.67M 0.53% 29
2017
Q4
$1.99B Sell
36,986,918
-3,751,072
-9% -$208M 0.52% 30
2017
Q3
$2.49B Sell
40,737,990
-1,659,589
-4% -$101M 0.69% 17
2017
Q2
$2.59B Sell
42,397,579
-2,774,066
-6% -$169M 0.73% 16
2017
Q1
$2.74B Sell
45,171,645
-2,060,875
-4% -$125M 0.76% 15
2016
Q4
$2.65B Sell
47,232,520
-12,204,155
-21% -$714M 0.76% 17
2016
Q3
$3.54B Buy
59,436,675
+1,294,693
+2% +$75.7M 1.05% 8
2016
Q2
$3.2B Sell
58,141,982
-1,619,046
-3% -$86.2M 0.98% 7
2016
Q1
$3.02B Sell
59,761,028
-305,885
-0.5% -$15M 0.91% 10
2015
Q4
$3.03B Buy
60,066,913
+203,546
+0.3% +$10.3M 0.91% 10
2015
Q3
$2.82B Buy
59,863,367
+6,747,662
+13% +$358M 0.86% 11
2015
Q2
$2.89B Sell
53,115,705
-147,798
-0.3% -$8.29M 0.8% 13
2015
Q1
$2.92B Sell
53,263,503
-3,441,218
-6% -$195M 0.76% 17
2014
Q4
$3.07B Sell
56,704,721
-2,605,471
-4% -$145M 0.8% 15
2014
Q3
$3.35B Buy
59,310,192
+226,169
+0.4% +$12.7M 0.91% 11
2014
Q2
$3.26B Sell
59,084,023
-921,221
-2% -$50.3M 0.88% 11
2014
Q1
$3.25B Buy
60,005,244
+4,335,558
+8% +$225M 0.89% 13
2013
Q4
$2.66B Buy
55,669,686
+1,379,497
+3% +$63.1M 0.74% 18
2013
Q3
$2.47B Sell
54,290,189
-3,021,670
-5% -$138M 0.73% 21
2013
Q2
$2.54B Buy
+57,311,859
New +$2.56B 0.8% 18

Other funds holding MRK

Bank of New York Mellon's MRK Position: Q2 2026 in Review

Bank of New York Mellon reduced its Merck (MRK) stake by 2% in Q2 2026, selling an estimated $43.7M and leaving 18,340,173 shares worth $2.36B. The position accounts for 0.39% of the portfolio, ranked #44.

Bank of New York Mellon first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.54B in Q3 2016. 2,995 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bank of New York Mellon held 18,340,173 shares of Merck worth $2.36B as of Q2 2026.
  • Bank of New York Mellon sold 373,190 Merck shares in Q2 2026, an estimated $43.7M.
  • Merck made up 0.39% of Bank of New York Mellon's portfolio in Q2 2026, its #44 holding.
  • Bank of New York Mellon first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Merck position peaked at $3.54B in Q3 2016.
  • 2,995 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.